tirzepatide coming off shortage list Eli Lilly's drugs removed from FDA FDA says shortage of Ozempic

These findings are exciting because they suggest GLP-1 receptor agonists could have broader kidney-protective effects than initially thought, said the papers first author, Jefferson Triozzi, MD, MSCI, instructor in Medicine in the Division of Nephrology and Hypertension at VUMC

Why state matters for GLP-1 providers Healthcare is regulated state by state

VK2735 VK2535 is a novel GLP-1 and GIP dual agonist (similar to tirzepatide)

241 In lenvatinib-resistant HCC, CDK6-mediated phosphorylation of GSK3 at Ser9 stabilizes -catenin and promotes its nuclear translocation, reinforcing CSC phenotypes and immune evasion

Efficient communication also matters